These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30203132)

  • 21. RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cells.
    Wang X; Peden K; Murata H
    Vaccine; 2015 Dec; 33(51):7254-7261. PubMed ID: 26552003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.
    Lilleri D; Gerna G; Furione M; Zavattoni M; Spinillo A
    J Clin Virol; 2016 Aug; 81():16-24. PubMed ID: 27289427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An enzyme immunoassay based micro-neutralization test for titration of antibodies to human cytomegalovirus (CMV) and its correlation with direct ELISA measuring CMV IgG antibodies.
    Gupta CK; Leszczynski J; Gupta RK; Siber GR
    Biologicals; 1996 Mar; 24(1):41-9. PubMed ID: 8733600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cells.
    Qi Y; He L; Cui X; Hertel L; Freed DC; Fu TM; Kauvar LM; McVoy MA; Ruan Q
    Virol J; 2020 Apr; 17(1):50. PubMed ID: 32268919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus.
    Fu TM; Wang D; Freed DC; Tang A; Li F; He X; Cole S; Dubey S; Finnefrock AC; ter Meulen J; Shiver JW; Casimiro DR
    Vaccine; 2012 Dec; 30(52):7469-74. PubMed ID: 23107592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploiting 2A peptides to elicit potent neutralizing antibodies by a multi-subunit herpesvirus glycoprotein complex.
    Wussow F; Chiuppesi F; Meng Z; Martinez J; Nguyen J; Barry PA; Diamond DJ
    J Virol Methods; 2018 Jan; 251():30-37. PubMed ID: 28989096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies.
    Ciferri C; Chandramouli S; Leitner A; Donnarumma D; Cianfrocco MA; Gerrein R; Friedrich K; Aggarwal Y; Palladino G; Aebersold R; Norais N; Settembre EC; Carfi A
    PLoS Pathog; 2015 Oct; 11(10):e1005230. PubMed ID: 26485028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of relationships between polymorphisms in the genes encoding the pentameric complex and neutralization of clinical cytomegalovirus isolates.
    Kobayashi R; Abe M; Oguri K; Torikai M; Nishimura T; Mori H; Koshizuka T; Inoue N
    Vaccine; 2018 Sep; 36(40):5983-5989. PubMed ID: 30174240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
    Park JW; Kim DJ; Kim J; Park CG; Hwang ES; Cha CY
    J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections.
    Genini E; Percivalle E; Sarasini A; Revello MG; Baldanti F; Gerna G
    J Clin Virol; 2011 Oct; 52(2):113-8. PubMed ID: 21820353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrafamilial transmission of human cytomegalovirus (HCMV): long-term dynamics of epitope-specific antibody response in context of avidity maturation.
    Hamprecht K; Bissinger AL; Arellano-Galindo J; Schweinzer K; Jiang X; Göhring K; Mikeler E; Jahn G
    J Clin Virol; 2014 Jun; 60(2):119-26. PubMed ID: 24742599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission.
    Vanarsdall AL; Chin AL; Liu J; Jardetzky TS; Mudd JO; Orloff SL; Streblow D; Mussi-Pinhata MM; Yamamoto AY; Duarte G; Britt WJ; Johnson DC
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3728-3733. PubMed ID: 30733288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of HCMV specific IgG subclass antibody levels with gender and age.
    Simon B; Kundi M; Puchhammer-Stöckl E
    Exp Gerontol; 2013 May; 48(5):472-5. PubMed ID: 23422355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex.
    Zydek M; Petitt M; Fang-Hoover J; Adler B; Kauvar LM; Pereira L; Tabata T
    Viruses; 2014 Mar; 6(3):1346-64. PubMed ID: 24651029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dimerized single-chain variable fragment system for the assessment of neutralizing activity of phage display-selected antibody fragments specific for cytomegalovirus.
    Carlsson F; Trilling M; Perez F; Ohlin M
    J Immunol Methods; 2012 Feb; 376(1-2):69-78. PubMed ID: 22154743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies.
    Kabanova A; Perez L; Lilleri D; Marcandalli J; Agatic G; Becattini S; Preite S; Fuschillo D; Percivalle E; Sallusto F; Gerna G; Corti D; Lanzavecchia A
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17965-70. PubMed ID: 25453106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strain-specific neutralization of human cytomegalovirus isolates by human sera.
    Klein M; Schoppel K; Amvrossiadis N; Mach M
    J Virol; 1999 Feb; 73(2):878-86. PubMed ID: 9882288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Human anti-HCMV neutralizing Fab antibody generated by phage display library].
    Duan T; Liang MF; Gu SY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):247-50. PubMed ID: 15340569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement and assessment of cytomegalovirus of immunoglobulin (Ig) g titer in preparations.
    Shibaguchi H; Yamamoto T; Kuroki M; Futagami K
    Yakugaku Zasshi; 2010 Jul; 130(7):977-82. PubMed ID: 20606378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.